NAMS earnings: a positive outcome, +12.5%

On May 7, 2026, NewAmsterdam Pharma Co N.V. reached its earnings. The result was a positive outcome, and the stock moved +12.5% in the window around the event. It had already run -11.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.